222 / 386
20.2 Notes to the consolidated financial statements for the year ended December 31, 2016
FINANCIAL INFORMATION CONCERNING ASSETS,
FINANCIAL POSITION AND FINANCIAL PERFORMANCE
20
Share in net income of joint ventures and associates
(in millions of euros)
December 31, 2016
December 31, 2015
Adwen
(14)
(26)
Other joint ventures
(1)
(1)
Total joint ventures
(15)
(27)
Total associates
1
1
TOTAL
(14)
(26)
OPERATIONS HELD FOR SALE
Investments in joint ventures and associates
(in millions of euros)
December 31, 2016
December 31, 2015
Operations held for sale in 2015
AREVA NP
94
103
AREVA TA
-
-
Nuclear Measurements
-
-
Sub-total
94
103
Operations held for sale in 2016
NewCo
17
Adwen
61
Sub-total
78
TOTAL (*)
172
103
* see note 3.
Share in negative net equity of joint ventures and associates
(in millions of euros)
December 31, 2016
December 31, 2015
Operations held for sale in 2015
New NP
-
30
AREVA TA
-
-
Nuclear Measurements
-
-
Sub-total
-
30
Operations held for sale in 2016
NewCo
63
TOTAL (*)
63
30
* see note 3.
Enrichment Technology Company (ETC) is a joint venture held in equal shares by
AREVA and Urenco. Its main activity is to build, assemble and install centrifuges
and associated piping systems enabling its customers to enrich uranium. ETC
is also involved in the design of ultracentrifugation enrichment plants to meet its
customers’ needs and in project management for the construction of these facilities.
AREVA considers that it has an implicit obligation to ensure the continuity of ETC
operations; consequently, and in accordance with the provisions of IAS 28, AREVA
recognizes its share of negative equity under liabilities on its consolidated balance
sheet and its share of negative net income on its statement of income and statement
of consolidated comprehensive income.
222
2016 AREVA
REFERENCE DOCUMENT